Abstract
BackgroundAdoptive and antibody-based immunotherapies are highly successful in the clinic for the treatment of certain malignancies. However, effective immunotherapy targets remain elusive for various cancers, in particular metastatic diseases. Certain...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
